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ABSTRACT
We have previously shown that overexpression of the Glud1
(glutamate dehydrogenase 1) gene in neurons of C57BL/6
mice results in increased depolarization-induced glutamate
release that eventually leads to selective neuronal injury and
cell loss by 12 months of age. However, it is known that
isogenic lines of Tg (transgenic) mice produced through
back-crossing with one strain may differ in their phenotypic
characteristics from those produced using another inbred
mouse strain. Therefore, we decided to introduce the Glud1
transgeneintotheBalb/cstrainthat hasendogenouslylower
levels of GLUD1 (glutamate dehydrogenase 1) enzyme
activity in the brain as compared with C57BL/6. Using an
enzyme-based MEA (microelectrode array) that is selective
for measuring glutamate in vivo, we measured depolariza-
tion-induced glutamate release. Within a discrete layer of
the striatum, glutamate release was significantly increased
in Balb/c Tg mice compared with wt (wild-type) littermates.
Furthermore, Balb/c mice released approx. 50–60% of the
amount of glutamate compared with C57BL/6 mice. This is
similar to the lower levels of endogenous GLUD1 protein in
Balb/c compared with C57BL/6 mice. The development of
these Glud1-overexpressing mice may allow for the
exploration of key molecular events produced by chronic
exposure of neurons to moderate, transient increases in
glutamate release, a process hypothesized to occur in neuro-
degenerative disorders.
Key words: amperometry, biosensor, electrochemistry,
excitotoxicity, neurodegeneration, neurotransmission.
INTRODUCTION
In an effort to generate experimental animals that might
exhibit structural and functional changes in the brain as a
result of life-long, moderately excessive release of glutamate
from neurons, we created Tg (transgenic) mice that express
the gene for Glud1 (glutamate dehydrogenase 1) in CNS
(central nervous system) neurons (Bao et al., 2009). Based on
our observations with these Tg mice (Glud1 mice), GLUD
(glutamate dehydrogenase) appears to be a key enzyme in
regulating the amount of glutamate synthesized and released
from CNS neurons (Bao et al., 2009). This is an important
observation, because the Glud1 gene has been identified as a
memory-related gene in the hippocampus (Cavallaro et al.,
1997) and dysregulation of a related Glud gene expressed in
the human brain, Glud2, has been associated with early onset
of Parkinson’s disease (Plaitakis et al., 2010). The reason for
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asnneuro.org / Volume 3 (2) / art:e00057 99focusing on excess glutamate synthesis in CNS neurons is
based on the fact that glutamate is not only the most
prevalent excitatory neurotransmitter in the vertebrate CNS,
but that it also has long-lasting effects on neuronal function,
such as the establishment of long-term potentiation or
depression of synaptic transmission (Artola and Singer, 1987;
Cotman et al., 1988; Ito, 1989), and on neuronal structure,
such as the initiation of neuronal migration, axonal growth
and synapse formation during development (Mattson et al.,
1988; Brewer and Cotman, 1989; Komuro and Rakic, 1993).
Interest in the endogenous activity of glutamate goes beyond
the role of this neurotransmitter in learning and memory.
Acute treatment of neurons with high concentrations of
glutamate leads to neurotoxicity, thus offering a possible link
to neurodegenerative diseases (Choi and Rothman, 1990).
In our previous study of heterozygous Glud1 Tg mice, we
found that chronic, moderate excess release of glutamate in
these mice as compared with wt (wild-type) littermates, led
to selective neuronal injury and moderate cell loss with
advancing age (Bao et al., 2009). Overexpression of Glud1
only in CNS neurons significantly increased synaptic glutam-
ate release, decreased synaptic long-term potentiation and
decreased synapse numbers in selective brain regions. The Tg
mice used in these studies were mice that were back-crossed
to the C57BL/6 strain, a strain of mice frequently used for
biochemical, physiological and behavioural studies. However,
it is known that isogenic lines of Tg mice produced through
back-crossing with one strain may differ in their phenotypic
characteristics from those produced using another inbred
mouse strain (Crawley et al., 1997). The diversity of
phenotypic characteristics of Tg mice may result from
behavioural, physiological or biochemical differences among
such strains. For example, inbred strains of C57 mice, such as
C57BL/6, have high levels of exploratory activity and low
‘emotional’ or anxiety levels, whereas albino inbred mice,
such as the Balb/c strain, exhibit low levels of exploratory
activity and high levels of anxiety (Crabbe, 1986; Mathis
et al., 1994). These two strains of mice differ also in several
neurochemical parameters (i.e. endophenotype), including
brain serotonin, the neurosteroid 17-OH-pregnenolone, and
the formation of reactive oxygen species in hippocampal
neurons in response to glutamate-induced stress (Zhang
et al., 2004; Tagawa et al., 2006; Palumbo et al., 2010). Other
examples of endophenotypic variation among several strains
of mice have been documented and include significant
differences in the levels of gene and protein expression in the
hippocampus (Fernandes et al., 2004; Pollak et al., 2006).
It is possible to select different strains of mice to generate
isogenic lines based on the expected effects that a transgene
or targeted gene disruption would have on specific beha-
viours. However, in a situation such as the Glud1 Tg mice for
which the expected behavioural manifestations of the
transgene are unknown, a choice of a specific strain on
behavioural grounds is not possible. In such a situation, it is
important to use more than one strain of mice as the
background strain, especially strains that may significantly
differ in terms of their behaviours and their physiological or
biochemical characteristics. Therefore we decided to intro-
duce the Glud1 transgene into a second strain, one that we
determined had endogenously lower levels of GLUD1
(glutamate dehydrogenase 1) enzyme activity in brain as
compared with the C57BL/6 mice.
In the present study, we demonstrated that Balb/c mice had
lower protein levels of GLUD1, as well as lower neuronal GLUD
activity, therefore, fulfilling the criteria for a mouse strain
with low endogenous GLUD1 expression that may be used for
the generation of a new isogenic line of mice bearing the
transgene for Glud1. Following back-crossing of the Tg mice to
the Balb/c strain, we measured the effects that introduction
of the Glud1 gene had on basal extracellular glutamate levels
and on depolarization-induced glutamate release from striatal
neurons in these mice and compared such release with that
observed in littermate wt mice and C57BL/6 mice over-
expressing the same transgene. We decided to study striatal
glutamate release based on previous results indicatingdendrite
and cell body injury (decreases in MAP2A labelling) but
relatively well-preserved nerve endings (no changes in
synaptophysin labelling) in the striatum of C57BL/6 Glud1
mice (Bao et al., 2009). Unlike the striatum, the hippocampus
of Glud1 mice, and especially the CA1 region of the hippo-
campus, suffered dendrite and nerve terminal losses. Therefore
glutamate release measurements in the striatum would not be
compromised by substantial nerve terminal losses. In order to
study glutamate release in these strains of mice, we utilized an
enzyme-based MEA (microelectrode array) selective for
measuring glutamate with low limits of detection (,0.2 mM),
high spatial resolution (333615 mm), fast temporal resolution
(500 ms) (Burmeister and Gerhardt 2001; Burmeister et al.,
2000, 2002, 2004) and minimal damage to surrounding brain
tissue (50–100 mm) (Hascup et al., 2009).
METHODS
Generation of Balb/c GLUD Tg mice
All experimental procedures related to animals followed
the procedures of the Institutional Animal Care and Use
Committees of the University of Kansas and the University
of Kentucky, as well as those of the National Institutes of
Health. Efforts were made for minimizing the number of ani-
mals used. On arrival from the University of Kansas, mice
(10–12 months of age) were quarantined for a minimum of 1
week in the DLAR (Division of Laboratory Animal Resources)
at the University of Kentucky. Mice were group housed under
a 12 h light/12 h dark regime with food and water ad libitum.
All appropriate animal care (food, water, bedding, cage
cleaning, etc.) was performed by DLAR staff. Following
experimentation, the mice were killed with an overdose of
anaesthetic followed by decapitation.
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Glud1 were generated by microinjecting oocytes from hyper-
ovulating C57BL6/SJL hybrid mice with linearized DNA
containing the cDNA for mouse Glud1 under the control of
the promoter for neuron-specific enolase. The construct
of the cDNA for Glud1, the oocyte microinjection procedure
and the identification of the four founder mice carrying the
transgene were described previously (Bao et al., 2009).
The founder Tg mice were each cross-bred to Balb/c mice
and heterozygous Tg mice identified by PCR methods (Bao
et al., 2009). Cross-breeding with Balb/c mice has been
carried out for more than ten generations.
Measurement of GLUD activity and GLUD1
protein levels in brain homogenates and
synaptosomes
Whole brains from adult C57BL/6, Balb/c and CD-1 mice were
obtained following decapitation under anaesthesia (CO2)
and were homogenized in ice-cold buffer (0.32 M sucrose,
0.5 mM MgSO4, 10 mM amino caproic acid, 0.1 mM EGTA,
0.1 mM benzamide, 0.1 mM benzamidine hydrochloride, in
10 mM Hepes buffer, pH 7.4). The homogenates were ra-
pidly frozen in liquid N2 and stored at 280˚C until used.
Synaptosomes were isolated from freshly prepared brain
homogenates using Ficoll
TM gradient centrifugation proce-
dures identical with those previously described (Chen et al.,
1988). Protein content in all preparations was measured as
described (Michaelis et al., 1983).
The enzyme activity of GLUD was measured in the direction
of glutamate oxidation and deamination using a coupled
reaction scheme similar to that described (Maeda et al., 1989;
Tsuji et al., 1989). In this scheme, the NADH formed during
varying incubation time periods was allowed to reduce O2 to
O2
2N and H2O2 in a coupled reaction with the electron
mediator 1-MPMS (1-methoxy-5-methylphenazinium
methyl-sulfate). The O2
2N and H2O2 formed were detected
as light generated by the chemiluminescence reaction with
isoluminol in the presence of m-POD (micro-peroxidase)
(Maeda et al., 1989; Tsuji et al., 1989). The GLUD enzyme
reactions with brain homogenates were performed in 96-well
chemiluminescence microplates and were initiated by the
addition of 10 ml of homogenate (50 mg/ml final protein
concentration) to 90 ml of reaction buffer (final concentra-
tions in mM: 125.0 ammonium acetate, 1.0 EDTA, 0.9 NAD,
1.0 ADP, 1.0 leucine, 20.0 L-glutamate and 50.0 triethano-
lamine, pH 7.5). Following incubation at 23˚C for 15 min, the
NADH formed was estimated by adding to the wells 100 mlo f
50 mM 1-MPMS and after 30 s, 100 ml of a 1:1 mixture
of 0.24 mM isoluminol in 0.8 M carbonate buffer, pH 9.5,
and 1 mM m-POD. The chemiluminescence signal was mea-
sured for 5 s at 15 s after the addition of isoluminol and
m-POD. Different concentrations of NADH in the absence of
any enzyme were used to measure the relationship of light
emitted to NADH concentration and these values were
used to estimate the specific activity of GLUD in brain
homogenates. When purified liver GLUD1 enzyme activity
was being measured for the standardization of the assay
method, the protein added to the reaction buffer was 1 mg/ml
final concentration.
The protein levels for GLUD1 in brain homogenates were
estimated by two different procedures, immunoblot assays
following SDS/PAGE of brain proteins and ELISA of Glud1 in
brain homogenates. These procedures were performed as
previously described (Babcock et al., 1996; Pal et al., 2003;
Bao et al., 2009) using affinity-purified anti-GLUD1 antibody
(1:1000 dilution, Sigma–Aldrich).
Glutamate measurements using MEAs
Enzyme-based MEAs with Pt (platinum) recording surfaces
were fabricated, assembled and calibrated for in vivo mouse
recordings according to published literature (Hascup et al.,
2006; Burmeister et al., 2000). For selective glutamate
recordings, two of the MEA recording sites were coated with
an L-glutamate oxidase (EC 1.4.3.11) (Seikagaku America, East
Falmouth, MA, U.S.A.) coating solution as previously described
(Nickell et al., 2005). The remaining two MEA recording sites
(self-referencing or sentinel sites) were coated similar to the
glutamate recording sites, with the exception that the coating
solution did not contain L-glutamate oxidase. When the re-
cordedsentinelsitecurrentwassubtractedfromtheglutamate
recording site current, the resulting signal represented the
neuronal extracellular glutamate concentration (Burmeister
and Gerhardt, 2001; Burmeister et al., 2002).
All Pt recording surface were electroplated with mPD
(1,3-phenylenediamine) (5 mM; Acros Organics; Morris Plains,
NJ, U.S.A.) using the FAST16mkII recording system as
previously described (Stephens et al., 2009; Hinzman et al.,
2010). This created an exclusion layer that restricts the pas-
sage of ascorbic acid, dopamine and 3,4-dihydroxyphenylacetic
acid. Each MEA was calibrated prior to implantation as
previously described (Nickell et al., 2005). A total of
nine MEAs were used in the present study and they had
an average (¡S.E.M.) glutamate sensitivity of 7.5¡0.3
pA/mM, selectivity ratio of 127¡27 to 1, and LOD (limit of
detection) of 0.6¡0.2 mM based on a signal-to-noise ratio
of 3.
The MEA assemblies for in vivo recordings consisted of an
enzyme-based working electrode and a single-barrel glass
micropipette (internal tip diameter, 12–15 mm) positioned at
an equal distance from the four recording electrode sites
(BurmeisterandGerhardt,2001; Burmeister et al.,2002). Either
an isotonic solution of 70 mM KCl (70 mM KCl, 79 mM NaCl
and 2.5 mM CaCl2, pH 7.4) or a 5 mM glutamate solution (in
physiological saline, pH 7.4) was loaded into the single-barrel
glass micropipette. Glud1 and wt mice were anaesthetized
( 1 . 2 5g / k gu r e t h a n e ,i n t r a p e r i t o n e a l l y )a n dp l a c e di na
stereotaxic frame fitted with a mouse adaptor in a manner
similar to that described recently (Burmeister et al., 2002; Bao
et al., 2009). A 200-mm-diameter Ag/AgCl reference electrode
was implanted into the frontal cortex at a site remote from the
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101recording areas. The MEA assemblies were lowered into the
striatum in steps of 500 mm (Friedemann and Gerhardt, 1992)
using the co-ordinates for mouse brain (from bregma:
anteroposterior, +1.3; mediolateral, ¡1.5; DV (dorsoventral),
22.25 mm to 23.75 mm; Franklin and Paxinos, 1997).
Solutions were ejected from the glass micropipette using a
Picospritzer II (Parker Hannifin). The volume ejected was
monitored using a stereomicroscope fitted with a reticule
(Friedemann and Gerhardt, 1992). Constant voltage ampero-
metry was performed using a Fast Analytical Sensing
Technology (FAST16mkII) electrochemistry instrument
(Quanteon) and FAST software for four-channel simultaneous
recordings (Burmeister and Gerhardt, 2001).
A constant volume of 70 mM KCl (50–150 nl) was used to
elicit glutamate release in the striatum of both groups. This
stimulus range was chosen since volumes above 150 nl did
not increase the amount of measurable glutamate. Therefore,
the stimulus was determined to elicit the maximal amplitude
of glutamate release (peak concentration in micromolar).
After a stable baseline at each recording depth in the
striatum was reached (,10 min), ten signals per recording
site were obtained. Stimulations were locally applied 1 min
apart to allow sufficient clearance of the released glutamate
from the extracellular space. These signals were averaged into
a single data point, thus generating one data point for each
DV position and a maximum of four data points per pass in
the striatum of either hemisphere.
Amperometric data, time and pressure ejection marks for
each individual Pt recording site were saved in the recording
system. A modified Excel spreadsheet, in conjunction with
individual electrode calibration constants, was used to
analyse the glutamate curves. For the calculation of uptake
rate kinetics (micromolar per second), only amplitudes of
exogenously applied 5 mM L-glutamate (in physiological
saline; pH 7.4) between 3 and 13 mM were used in the
analyses. Uptake followed first-order-rate kinetics; therefore
the uptake rate constant (k21) was the logarithmic slope of
glutamate concentration versus time (s
21) estimated by use
of regression analyses (R
2>0.9). Multiplication of k21 with
the maximum amplitude of glutamate signal yielded the
uptake rate (micromolar per second).
Statistical analyses
Results from all assays were analysed using either one-way
ANOVA with post-hoc pairwise analysis (Bonferroni) for
multiple group comparisons, or by paired t-test for two group
comparisons, as noted. For averaged glutamate release
studies, a two-tailed t-test was used to compare Balb/c
Glud1 wt and Tg mice. In addition, a two-way ANOVA
followed by a Bonferroni post-hoc was used to analyse
recording depth variations in resting glutamate, depolariza-
tion-induced glutamate release and clearance of glutamate.
Results are shown as means¡S.E.M. and significance was
defined as P,0.05.
RESULTS
Selection of a mouse strain with low endogenous
GLUD1 activity
Based on previous behavioural observations that C57BL/6
exhibit very different behavioural characteristics than Balb/c
mice, we decided to include these two strains in a direct
comparison of relative enzyme activities and levels of the
brain GLUD1 protein. As a control for the effects of mouse
inbreeding, we also added an outbred strain, the CD-1 mice.
In order to enhance the sensitivity of the GLUD assay
procedure, we used a chemiluminescence detection method
of coupled reactions as described in the Methods section
(Maeda et al., 1989; Tsuji et al., 1989). The limits of detection
of NADH formed using the chemiluminescence procedure
were approx. 1000-fold lower than those established using a
fluorescence detection method (results not shown). Prior to
the initiation of measurements of brain GLUD1 activity in the
three mouse strains, the chemiluminescence procedure for
the detection of glutamate oxidation and deamination by
GLUD1 was validated using purified liver enzyme. The kinetic
characterization of purified liver GLUD1 performed across
different glutamate concentrations and in the presence of 0.9
mM NAD
+ and the enzyme activators leucine and ADP (1
mM), led to an estimated Km for the enzyme equal to 8.4 mM.
This value of the Km for glutamate of the purified liver GLUD1
measured at pH 7.5, was intermediate between the reported
Km for the enzyme measured at pH 6 (Km522.7 mM) and that
at pH 8 (Km54.9 mM) (Bailey et al., 1982). Thus, the
chemiluminescence procedure appeared to be both sensitive
and accurate in the detection of GLUD activity.
The enzyme activity in whole brain homogenates from
C57BL/6, CD-1 and Balb/c, mice was measured at a single
glutamate (20 mM) and NAD
+ (0.9 mM) concentration, under
conditions identical with those used for the liver enzyme,
including the GLUD1 activators leucine and ADP. A high
glutamate concentration was used so that the enzyme
activity would approximate the Vmax for GLUD1 as deter-
mined in the studies with purified liver enzyme. The NAD
+
concentration used was near that of the estimated Km for
liver GLUD1 when measured in the presence of ADP (Bailey
et al., 1982). The results from the measurements of GLUD1
activity (glutamate deamination and oxidation) in brain
homogenates from the three mouse strains indicated
significantly lower enzyme activity in Balb/c as compared
with either C57BL/6 or CD-1 mice (Figure 1A). The outbred
strain CD-1 had very similar GLUD1 activity to that of C57BL/
6 (Figure 1A).
The differences in GLUD1 activity might have been related
to differential levels of the GLUD protein in the brains of
Balb/c mice compared with those in C57BL/6 or CD-1. In
order to explore this possibility, brain homogenates from
C57BL/6, CD-1 and Balb/c mice were analysed by ELISA
and immunoblot assays. Determination of the levels of
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102 E 2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.immunoreactive protein by ELISA was indicative of signifi-
cantly lower levels of GLUD1 protein in Balb/c brain
homogenates than either those in C57BL/6 or CD-1
(Figure 1B). Once again, there was no statistically significant
difference detected between C57BL/6 and CD-1 GLUD1 levels
in brain homogenates. The results from the ELISA assays were
confirmed by the observations made in immunoblot assays
(Figure 1B). The antibody labelling of the band at 60 kDa
corresponding to the GLUD1 protein in these blots was, again,
significantly weaker in Balb/c mice compared with either
C57BL/6 or CD-1 mice.
Using brain homogenates for the enzyme and immune
assays of GLUD1 did not allow for the discrimination between
neuronal and glial forms of GLUD1. In order to assess the
activity of GLUD in a neuronal compartment, we isolated
synaptosomes from brain homogenates of C57BL/6, CD-1 and
Balb/c mice. Enzyme activity in synaptosomes was measured
under conditions identical with those used for homogenates.
Once again, GLUD activity in synaptosomes isolated from
Balb/c mice was significantly lower than that of synapto-
somes from C57BL/6 or CD-1 mouse brains (Figure 1C). The
GLUD activity in the purified synaptosome fraction from
C57BL/6 brains (2.38 mmol/mg of protein, Figure 1C) was
substantially higher than that in whole brain homogenates
from these mice (1.28 mmol/mg of protein, Figure 1A), an
indication that GLUD activity was enriched in this fraction
that represented the intraneuronal compartment of synapses.
Resting glutamate levels in Balb/c Glud1 Tg mice
In order to determine changes in tonic levels (i.e., basal levels)
of striatal glutamate in Balb/c wt and Tg mice, resting
glutamate levels were calculated in each mouse group as
previously described (Day et al., 2006; Rutherford et al., 2007;
Hascup et al., 2008). Briefly, the self-referencing electrode
current was subtracted from the glutamate recording elec-
trode current (and divided by the glutamate recording site
slope obtained from in vitro calibration). As shown in
Figure 2(A), there was no difference in resting glutamate
levels in Balb/c Glud1 wt (0.8¡0.1 mM; n55) and Tg
(0.8¡0.2 mM; n54) mice. Because of the small size of our
recording sites (333615 mm), we were able to monitor
resting glutamate levels in several DV positions in the
striatum. As shown in Figure 2(B), this analysis indicated
minor differences among the brain regions between Balb/c
Glud1 wt and Tg mice, and a two-way ANOVA showed no
effect of the mouse genotype at any recording depth.
Depolarization-induced glutamate release
Local application of 70 mM KCl for 1–2 s in the striatum of Tg
and wt mice produced robust, reproducible changes in
extracellular glutamate that were consistently higher in Tg
mice (Figure 3A). For consistency in data analysis, only
glutamate signals elicited by ejections of 50–150 nl of 70
mM KCl were analysed to obtain the average maximum
Figure 1 GLUD activity in C57BL/6, CD-1 and Balb/c mice
GLUD activity in brain homogenates and isolated synaptosomes, and immune
reactivity in brain homogenates fromC57BL/6,CD-1andBalb/cmice. (A) GLUD
activity in brain homogenates from the three inbred strains. The results
represent the means (¡S.E.M.) of triplicate determinations obtained from five
mice of each strain. Group comparison by one-way ANOVA indicated
significant differences in GLUD activity of brain homogenates among the
three strains (F513.41; P50.003). Pair-wise multiple comparisons of the three
strains indicated significant differences (Bonferroni t-test) between the
activity of homogenates from C57BL/6 and those from Balb/c, and between
those from CD-1 and from Balb/c. The differences between C57BL/6 and CD-1
homogenates were not statistically significant. In all graphs, **P,0.01 for pair-
wise statistical comparisons of Balb/c versus C57BL/6 mice, and {P,0.05 for
comparisons of Balb/c versus CD-1 mice. (B) ELISA assays of immune reactivity
of anti-GLUD1 antibodies with brain homogenates from the brains of the
C57BL/6, CD-1 and Balb/c mice. Results represent the means¡S.E.M.
of relative immunoreactivity as compared with that of C57BL/6 (set as
100%). The results were from triplicate determinations with three mice in each
inbred strain. Pair-wise statistical comparisons (t-test) indicated significant
differences between the GLUD immune reactivity of C57BL/6 and Balb/c mice,
and the immune reactivity of CD-1 and Balb/c mice. The differences in GLUD
immune reactivity between C57BL/6 and CD-1 brain homogenates were not
significant. Immunoblot demonstrations of differential levels of GLUD1 protein
in the three inbred strains of mice are shown beneath this graph. Brain homo-
genates (30 mg protein per lane) from three mice from each strain were run on
the same electrophoresis gel and labelled with anti-GLUD1 antibodies. Only
one band of 60kDa was labelled in all lanes containingbrain samples. (C) GLUD
activity in isolated synaptosomes from the brains of the three inbred strains.
The results represent the means (¡S.E.M.) of triplicate determinations
obtainedfromthree miceof eachstrain. Group comparison by one-way ANOVA
indicated significant differences among the three strains (F522.24; P50.002).
Pair-wise multiple comparisons of the three strains indicated significant
differences (Bonferroni t-test) between C57BL/6 and Balb/c, and between
CD-1 and Balb/c. The differences in GLUD activity between C57BL/6 and CD-1
synaptosomes were not significant.
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103amplitude of glutamate release in the striatum of wt and Tg
mice. Ejection volumes of KCl eliciting these signals were, on
average, nearly identical in wt (111¡4 nl) and Tg (116¡3 nl)
mice, yet the average maximum amplitude for glutamate
release was significantly (P,0.05) greater in Tg (5.2¡0.4 mM)
than wt (3.9¡0.4 mM) Balb/c mice (Figure 3B). Again, a depth
analysis profile was performed and regional variations were
observed between Balb/c wt and Tg mice (Figure 3C). Analysis
of the data by two-way ANOVA indicated a statistically
significant effect of genotype (F56.39, P50.01) as well as
a significant effect of interaction (F52.85, P50.04).
Bonferroni post-hoc analysis revealed that at DV 23.25
striatal glutamate release was significantly (P,0.01) greater
in Balb/c Tg (6.1¡0.7 mM) compared with wt (2.7¡0.4 mM)
mice.
Clearance of 5 mM L-glutamate
In order to assess the role that glutamate transport might play
in the differential levels of glutamate release in striatum
following depolarization, glutamate transport into neurons or
glia in the vicinity of the MEAs was also estimated by mea-
suring glutamate clearance after local application of nanolitre
volumes of 5 mM L-glutamate. Since neurotransmitter uptake
follows Michaelis–Menten kinetics (Nicholson, 1995) and is
known to be affected by the amount of available substrate,
glutamate clearance was analysed by selecting a subset of
signals with maximum release values in the range of 3–13 mM
Figure 2 Resting glutamate in the striatum of Balb/c Glud1 mice
Resting glutamate levels were determined in wt (n55) and Tg (n54) Balb/c
mice at four DV positions (22.25 to 23.75 mm in 0.5 mm increments) prior
to 70 mM KCl depolarization-induced glutamate release studies. No
differences in resting glutamate levels were observed across the entire
striatum (A) or at different DV positions within the striatum (B).
Figure 3 Depolarization-induced glutamate release
(A) Stimulus-evoked glutamate release in Balb/c wt (black) and Tg (grey) mice
following pressure ejection of 50–150 nl of 70 mM KCl (pH 7.4) in the
striatum as indicated by the arrows. Reproducible signals of glutamate
release were obtained from both mouse groups, Signals of glutamate release
from striatal neurons of Balb/c Glud1 Tg mice were consistently greater than
those recorded from neurons of wt mice. (B) The average volumes of 70 mM
KCl used to elicit depolarization-induced striatal glutamate release were:
wt5111¡4 nl and Tg5116¡3 nl. These values did not differ significantly.
The average maximal amplitude of KCl-induced glutamate release was
significantly greater (*P,0.05) in the striatum of Balb/c Glud1 Tg (n54) mice
compared with wt Balb/c mice (n55). (C) Depth-related alterations in
average amplitude of stimulus-evoked glutamate release in the same two
mouse groups as in (B). Analysis of data using two-way ANOVA with
Bonferroni post-hoc indicated a significant (**P,0.01) increase in stimulus-
evoked glutamate release at DV 23.25 in the Balb/c Glud1 Tg (n54)
compared with glutamate release recordings at the same depth in wt
littermates (n55).
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because pressure ejection peak glutamate values in this range
were quite reproducible in both Balb/c wt (7.8¡0.3 mM, n55)
and Tg (8.3¡0.3 mM, n54) mice. The volume of 5 mM L-
glutamate solution ejected from the glass micropipette was
also similar in Balb/c Glud1 wt (26¡1 nl) and Tg (28¡3 nl)
mice. Within the subset of signals representing the concen-
tration range selected, clearance rates of exogenously applied
5m ML-glutamate were similar for wt (2.5¡0.2 mM/s) and Tg
(2.4¡0.2 mM/s) mice (Figure 4A). Also, a depth analysis profile
revealed no regional variation in the clearance of exogenously
applied glutamate in the striatum (Figure 4B).
Depolarization-induced glutamate release in
Balb/c compared with C57BL/6 mice
Since the main focus of the present study was to determine
whether the background strain of mice to which the founder
Glud1 Tg mice were back-crossed had any effects on synaptic
glutamate formation and release in vivo, we directly
compared depolarization-induced glutamate release in wt
and Tg Balb/c and C57BL/6 mice. We previously showed that
overexpression of the Glud1 gene in mice back-crossed to
C57BL/6 mice significantly increases depolarization-induced
glutamate release in these Tg mice compared with wt
littermates (Bao et al., 2009). Again, for consistency in data
analysis, only glutamate signals elicited by ejections of 50–
150 nl of 70 mM KCl in the striatum of Balb/c and C57BL/6 Tg
and wt mice were analysed to obtain the average maxi-
mum amplitude of glutamate release in all groups (volume
matched). Volumes of the KCl stimulus were similar in Balb/c
wt (111¡4 nl) to those in C57BL/6 wt (117¡4 nl), and the
same was true for Balb/c Tg (116¡3 nl) and C57BL/6 Tg
(120¡6 nl) mice. The C57BL/6 mice released significantly
more glutamate compared with the Balb/c mice (Figure 5). A
two-tailed t-test indicated that depolarization-induced
glutamate release was significantly lower in the Balb/c mice,
either wt or Tg (results presented above) when compared with
the glutamate release values of the respective genotype of
C57BL/6 mice: wt, 6.4¡1.0 mM, n59; P,0.01; and Tg:
10.2¡1.7 mM; n55; P,0.001. In other words, the Balb/c wt
and Glud1 Tg mice released 51–61% of the amount of
glutamate released following stimulation of striatal neurons
in C57BL/6 wt and Glud1 Tg mice respectively.
DISCUSSION
The observations made in our current studies that the Balb/c
mouse neurons had significantly lower endogenous levels of
GLUD enzyme activity and GLUD1 protein in comparison with
either C57BL/6 or an outbred strain, CD-1, are consistent with
the results of a recent proteomic analysis of differential
protein levels in the hippocampus of five inbred strains of
mice (Pollak et al., 2010). In that study, it was shown that
Figure 4 Clearance rate of exogenously applied 5 mM glutamate
(A) The clearance rate of exogenously applied 5 mM L-glutamate to the
mouse striatum was analysed by selecting a subset of signals with maximum
release values in the range of 3–13 mM. Peak values were similar in both
Balb/c wt (7.8¡0.3 mM, n55) and Tg (8.3¡0.3 mM; n54) mice as was the
rate of clearance. (B) When a depth profile was performed, no differences
were observed in the clearance rate of exogenously applied 5 mM
L-glutamate between wt and Tg Glud1 Balb/c mice.
Figure 5 Depolarization-induced glutamate release in Balb/c versus
C57BL/6 Glud1 mice
The average volume of 70 mM KCl used to elicit striatal glutamate release
was similar in Balb/c wt (111¡4 nl; n55) and Tg (116¡3 nl; n54) mice, as
well as in C57BL/6 wt (117¡4 nl; n59) and Tg (120¡6 nl; n55). De-
polarization-induced glutamate release was decreased in Balb/c Glud1 wt
(3.9¡0.4 mM) and Tg (5.2¡0.4 mM) mice compared with C57BL/6 Glud1
wt (6.4¡1.0 mM) and Tg (10.2¡1.7 mM) mice. **P,0.01, ***P,0.001.
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105Balb/c mice had the lowest GLUD1 protein levels of all strains
examined (Pollak et al., 2010). Thus the differences we
detected between Balb/c and C57BL/6 in the levels of GLUD1
protein in whole brain homogenates or synaptosomes appear
to be a molecular characteristic of this strain of mice. Our
findings were indicative of a diminished function of total
GLUD enzyme activity in whole brain and in synaptosomes of
Balb/c versus C57BL/6 or CD-1 mice. The low GLUD activity
and low GLUD1 protein levels thus led us to select the Balb/c
mouse strain for the back-crossing of the Glud1 Tg mouse
founders. The procedures used for back-crossing and
genotyping of mice were identical for both the C57BL/6
and the Balb/c mice (Bao et al., 2009). The endophenotypic
effects of overexpression of the Glud1 gene on brain function
in the Glud1 Tg Balb/c mice were assessed as the change in
glutamate release following KCl depolarization of neurons.
Resting glutamate levels in Balb/c Glud1 wt and Tg mice
were nearly identical, suggesting that the overexpression
of neuronal Glud1 had no effect on the tonic levels of
extracellular glutamate. Unfortunately, these values may be
misleading owing to the potential effects of urethane anaes-
thesia on tonic levels of glutamate in vivo. Urethane exerts
its effects predominantly through neurotransmitter-gated
ion channels to enhance inhibitory synaptic neurotransmis-
sion as well as inhibit excitatory neurotransmission (Hara and
Harris, 2002). Our laboratory has observed that resting
glutamate levels in brain are attenuated by 60–80% in
urethane-anaesthetized animals compared with freely mov-
ing rats (Rutherford et al., 2007). In fact, the tonic levels of
glutamate reported in the present study were reduced by
,80% compared with previously reported resting glutamate
values in awake, freely moving mice (,5 mM; Hascup et al.,
2008). These results are indicative of the need to exercise
caution when interpreting tonic levels of glutamate (or other
neurotransmitters) in anaesthetized animals.
Pressure ejection of 70 mM KCl elicited robust and
reproducible glutamate release in the striatum of both
Balb/c and C57BL/6 mice. This release was significantly
increased in the Balb/c Glud1 Tg versus wt mice, a finding
that was similar to the previously observed increases in
depolarization-induced glutamate release in Glud1 Tg C57BL/
6 mice (Bao et al., 2009). A depth analysis profile revealed
that this increase in glutamate release occurred at a
particular location within the striatum, at DV 23.25 mm.
Importantly, at this same recording depth we did not observe
any differences in the clearance of exogenously applied 5 mM
L-glutamate between Glud1 Balb/c wt and Tg mice. This
indicates that the increase in depolarization-induced glu-
tamate release was not the result of altered clearance
characteristics in the Tg mice.
When we compared the depolarization-induced glutamate
release in Balb/c mice with previously reported values for the
C57BL/6 Glud1 mice (Bao et al., 2009), an interesting trend
emerged. Using similar volumes of stimulus, the average
maximal amplitude of depolarization-induced glutamate
release in Balb/c wt and Glud1 Tg mice was 50–60% of the
amount released in C57BL/6 mice. This lower level of evoked
glutamate release corresponded to the decreased endogenous
GLUD1 protein levels and GLUD activity that we observed in
Balb/c compared with C57BL/6 mice.
One of the most intriguing findings from the current
studies was the observation that depolarization-induced
glutamate release was localized to the DV layer 23.25 within
the striatum, even though GLUD1 overexpression occurred in
all neurons in the brain (Bao et al., 2009). Unfortunately,
limited data exist for the neuroanatomical connections of the
mouse brain (Bohland et al., 2009), particularly a region that
lacks clear cytoarchitecture such as the striatum (Zeiss, 2005),
thus making interpretation of the results obtained from this
specific sub-region difficult. In mouse brain, it has previously
been shown that glutamatergic afferents to the striatum
originate in either the cortex (60%) or the thalamus (40%)
and may form synaptic contacts on the same medium spiny
neurons, yet it is the thalamostriatal neurons that have a
higher release probability as compared with corticostriatal
inputs (Ding et al., 2008). At DV 23.25, we may have recorded
from a unique proportion of these thalamostriatal neuronal
terminals and that these terminals might be the ones that
were selectively altered in the Balb/c Glud1 Tg mice, resulting
in the increased glutamate release.
A particular strength of using MEAs, especially compared
with other in vivo recording techniques such as microdialysis,
is the capability afforded by these electrodes to investigate
glutamate temporal dynamics at several recording depths of a
layered structure, such as the striatum. The heterogeneity of
multi-layered brain structures has been well characterized in
a number of studies using electrochemical methods. Using
carbon-fibre electrodes, Friedemann and Gerhardt (1992)
demonstrated a DV striatal gradient with respect to the
amount of potassium stimulation needed to evoke dopamine
release. Nickell et al. (2007) showed that the glutamate
clearance time was increased in the dorsal versus ventral
striatum as a function of aging in the Fischer 344 rat. More
recently, Stephens et al. (2009) showed significant changes
in stimulus-evoked release and re-uptake of glutamate in dif-
ferent hippocampal subregions with respect to aging in the
Fischer 344 rat. Collectively, these results support the idea
that nerve terminal projections within a specific brain
structure are not homogeneous in terms of distribution
and/or excitability, and it is necessary to analyse multiple
depths and not simply infer that results obtained from a
single layer are representative of the structure as a whole
(Nickell et al., 2007).
The primary finding of our study was that Balb/c Glud1 Tg
mice had significantly increased depolarization-induced
glutamate release compared with wt littermates, which was
similar to the results obtained with the C57BL/6 mice (Bao
et al., 2009). These observations were a clear indication that
introduction of the Glud1 transgene in neurons of pheno-
typically and endophenotypically different strains of mice
had very similar effects on neuronal release of glutamate.
Furthermore, these results provide strong evidence for the
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neurotransmission. The development of this Glud1-over-
expressing mouse model may allow for the exploration of
issues such as how chronic exposure of neurons to elevated
glutamate levels can affect the control of various behavioural
processes and of key molecular events that are hypothesized
to occur during aging and in neurodegenerative disorders.
While no behavioural changes were observed with the mice
used in the present study, further experiments are being
conducted to determine any behavioural phenotypes elicited
by overexpression of Glud1 with respect to age.
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